4//SEC Filing
Athyrium Opportunities Fund (A) LP 4
Accession 0000899243-20-017651
CIK 0001580063other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:18 PM ET
Size
32.7 KB
Accession
0000899243-20-017651
Insider Transaction Report
Form 4
PROGENITY, INC.PROG
Athyrium Opportunities Fund (B) LP
10% Owner
Transactions
- Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes)
Athyrium Opportunities Fund (A) LP
10% Owner
Transactions
- Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying)
Athyrium Opportunities 2020 LP
10% Owner
Transactions
- Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying)
Transactions
- Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes)
Transactions
- Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes)
Transactions
- Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes)
Transactions
- Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes)
Transactions
- Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying)
Athyrium Opportunities Associates LP
10% Owner
Transactions
- Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying)
Transactions
- Conversion
Common Stock
2020-06-23+1,250,000→ 23,303,346 total(indirect: See footnotes) - Conversion
Common Stock
2020-06-23+18,319,853→ 23,303,346 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total(indirect: See footnotes)→ Common Stock (18,319,853 underlying) - Purchase
Common Stock
2020-06-23$15.00/sh+3,333,333$49,999,995→ 23,303,346 total(indirect: See footnotes) - Conversion
Unsecured Convertible Promissory Note
2020-06-23(indirect: See footnotes)→ Common Stock (1,250,000 underlying)
Footnotes (7)
- [F1]Athyrium Opportunities 2020 LP directly owns 4,583,333 shares of the Issuer's common stock. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities 2020 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and President of Athyrium Opportunities Associates III GP LLC.
- [F2]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
- [F3]The Unsecured Convertible Promissory Note converted into 1,250,000 shares of the Issuer's common stock automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. Prior to conversion, the Unsecured Convertible Promissory Note had a maturity date of May 8, 2022.
- [F4]The Series B Preferred Stock converted into shares of the Issuer's common stock on a 0.162-for-one basis automatically without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The Series B Preferred Stock has no expiration date.
- [F5]The 4,211,977, 2,329,083, 7,603,040 and 4,175,753 shares of the Issuer's common stock issued on the conversion of the Series B Preferred Stock upon the closing of the initial public offering of the Issuer's common stock are held by Athyrium Opportunities Fund (A) LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities III Acquisition 2 LP and Athyrium Opportunities III Co-Invest 1 LP, respectively. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP.
- [F6](continued from footnote 5) Athyrium Opportunities Associates Co-Invest LLC is the general partner of Athyrium Opportunities III Co-Invest 1 LP. Athyrium Opportunities Associates GP LLC is the general partner of Athyrium Opportunities Associates LP, which is the general partner of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Opportunities Advisers LLC is the investment adviser of each of Athyrium Opportunities Fund (A) LP and Athyrium Opportunities Fund (B) LP. Athyrium Capital Management, LP is a member of Athyrium Opportunities Associates GP LLC and an investment sub-adviser of Athyrium Opportunities Advisers LLC. NB Alternatives GP Holdings LLC is also a member of Athyrium Opportunities Associates GP LLC. NB Alternatives Holdings LLC is the sole member of NB Alternatives GP Holdings LLC and is a member of NB Alternatives Advisers LLC.
- [F7](continued from footnote 6) NB Alternatives Advisers LLC is the sole member of Athyrium Opportunities Advisers LLC. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates Co-Invest LLC and Athyrium Opportunities Associates III GP LLC. Athyrium Capital Holdings, LLC is the general partner of Athyrium Capital Management, LP. Jeffrey A. Ferrell is the managing member of Athyrium Capital Holdings, LLC and Athyrium Funds GP Holdings, LLC and the President of Athyrium Capital Management, LP, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities Associates III GP LLC, and Athyrium Opportunities Associates GP LLC.
Documents
Issuer
PROGENITY, INC.
CIK 0001580063
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001589714
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:18 PM ET
- Size
- 32.7 KB